Immune Systems Advisor

If you've had COVID-19 or know someone who has, you've likely seen how the illness lingers. Unresolved fatigue, reduced physical capacity, and cognitive fog are common weeks or even months after the infection clears. In more severe cases, the virus left behind lasting damage to the kidneys, lungs, or vascular system. These outcomes are now recognized as long COVID. As attention shifts from short-term containment to long-term recovery, more researchers are focusing on the cellular pathways that support resilience after viral illness. One area drawing renewed attention is the use of nicotinamide adenine dinucleotide (NAD⁺), a molecule your cells use to produce energy, repair DNA, regulate inflammation, and maintain mitochondrial function. One of the most straightforward ways to raise NAD⁺ safely and effectively is through niacinamide, a common and inexpensive form of vitamin B3. Case in point, a new placebo-controlled trial published in Nature Metabolism has highlighted niacinami...

AgelessRx, an online telemedicine clinic that specializes in longevity, has launched a groundbreaking Pilot Post-COVID Clinical Trial. Through this clinical trial, they hope to identify and treat the underlying causes of Post-COVID-19 Syndrome and help “long-haulers” reduce or eliminate their symptoms and restore their quality of life. This Post-COVID Clinical Trial will enroll 60 adults between 18 and 65 of any gender and ethnicity for 12-weeks.  It is an IRB-approved clinical trial that will include a treatment and placebo group.  The individuals in the treatment group will receive 4.5mg/day of Low Dose Naltrexone (LDN) and 400mg/ml (worn once per week) of NAD+ Iontophoresis Patches.    AgelessRx’s Post-COVID Clinical Trial will further the research on the link between aging and COVID-19.  Despite the staggering amount of evidence, age related damage remains to be neglected when discussing treatment options for “long haulers.”  It is now understood ...